BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2052572)

  • 21. The human met oncogene is a member of the tyrosine kinase family.
    Gonzatti-Haces M; Park M; Dean M; Blair DG; Vande Woude GF
    Princess Takamatsu Symp; 1986; 17():221-32. PubMed ID: 3332011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of ras gene mutations in early gastric carcinomas.
    Craanen ME; Blok P; Top B; Boerrigter L; Dekker W; Offerhaus GJ; Tytgat GN; Rodenhuis S
    Gut; 1995 Dec; 37(6):758-62. PubMed ID: 8537044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRAS mutations predict progression of preneoplastic gastric lesions.
    Gong C; Mera R; Bravo JC; Ruiz B; Diaz-Escamilla R; Fontham ET; Correa P; Hunt JD
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):167-71. PubMed ID: 10067815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China.
    Ma JX; Zhang KL; Liu X; Ma YL; Pei LN; Zhu YF; Zhou L; Chen XY; Kong QY; Li H; Liu J
    Cancer Lett; 2006 Aug; 240(2):253-60. PubMed ID: 16337337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of oncogene c-Ha-ras in gastric cancer of Chinese patients.
    Deng G; Eh Z; Xu Y; Lu Y
    Semin Surg Oncol; 1994; 10(2):83-7. PubMed ID: 8052787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
    Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
    J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.
    Buchmann A; Bauer-Hofmann R; Mahr J; Drinkwater NR; Luz A; Schwarz M
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):911-5. PubMed ID: 1992483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant EphB/ephrin-B expression in experimental gastric lesions and tumor cells.
    Uchiyama S; Saeki N; Ogawa K
    World J Gastroenterol; 2015 Jan; 21(2):453-64. PubMed ID: 25593460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history of precursor lesions to gastric carcinoma: growth factors and oncogenes in the metaplasia-dysplasia-carcinoma sequence.
    Filipe MI
    Eur J Cancer Prev; 1994 Dec; 3 Suppl 2():19-23. PubMed ID: 7735041
    [No Abstract]   [Full Text] [Related]  

  • 30. The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer.
    Liu LM; Yan MG; Yang DH; Sun WW; Zhang JX
    Eur J Intern Med; 2011 Oct; 22(5):e31-5. PubMed ID: 21925039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
    Gomyo Y; Osaki M; Kaibara N; Ito H
    Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
    Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D
    Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
    Ebert MP; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz HU; Roessner A; Korc M; Malfertheiner P
    Cancer Res; 2000 Apr; 60(7):1995-2001. PubMed ID: 10766190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of gastrokine 1 in gastric mucosa of gastric cancer patients.
    Guo XY; Dong L; Qin B; Jiang J; Shi AM
    World J Gastroenterol; 2014 Nov; 20(44):16702-6. PubMed ID: 25469040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
    Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
    Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
    Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
    Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia.
    Szoke D; Molnár B; Solymosi N; Sipos F; Galamb O; Gyorffy A; Tulassay Z
    Dig Liver Dis; 2009 Mar; 41(3):179-84. PubMed ID: 18567547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activation of proto-oncogenes induced by MNNG on primary culture of human gastric epithelium and immortalized human gastric epithelial cell line].
    Wang B; Su X; Ke Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):6-9. PubMed ID: 8732101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk findings of the gastric mucosa--a clinicopathologic discussion].
    Heilmann KL; Lux G
    Leber Magen Darm; 1985 Jan; 15(1):1-12. PubMed ID: 3974395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.